Nintedanib Impurity 28 | CAS 2410649-54-4 - Request Quote
Nintedanib Impurity 28
| SZ CAT No: | SZ-N023044 |
| CAS No | 2410649-54-4 |
| Mol.F. | C22H26N6O6 |
| Mol.Wt. | 470.5 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Nintedanib Impurity 28 is chemically 2,2'-(piperazine-1,4-diyl)bis(N-methyl-N-(4-nitrophenyl)acetamide). Nintedanib Impurity 28 is supplied with detailed characterization data compliant with regulatory guideline. Nintedanib Impurity 28 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nintedanib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2410649-54-4
Purchase 2410649-54-4
Order 2410649-54-4
Enquire 2410649-54-4
price of 2410649-54-4
2410649-54-4 Supplier
2410649-54-4 Manufacturer
2410649-54-4 Exporter
buy high quality Nintedanib Impurity 28
Purchase Nintedanib Impurity 28
Nintedanib Impurity 28 suppliers
Nintedanib Impurity 28 manufacturers
Nintedanib Impurity 28 price
Order Nintedanib Impurity 28
Enquire Nintedanib Impurity 28
Nintedanib Impurity 28 cost
Nintedanib Impurity 28 Supplier
Nintedanib Impurity 28 Distributor
Nintedanib Impurity 28 for Method Validation
Nintedanib Reference Standard
Nintedanib Impurity 28 for ANDA Filing
Nintedanib Impurity 28 for Forced Degradation Studies
Nintedanib Impurity 28 Identification Standards
Nintedanib Impurity 28 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.